Pathology Research International / 2011 / Article / Fig 2

Research Article

Effects of the Demethylating Agent, 5-Azacytidine, on Expression of the Kallikrein-Kinin Genes in Carcinoma Cells of the Lung and Pleura

Figure 2

Effect of 5-azacytidine (5-AZA) on kallikrein-kinin mRNA expression in H2126 lung adenocarcinoma, H520 lung squamous cell carcinoma, and nonmalignant BEAS-2B lung epithelial cells. (a) Fold changes in mRNA expression for the tissue kallikrein (KLK1), plasma kallikrein (KLKB1), kinin B1 receptor (BDKRB1), and kinin B2 receptor (BDKRB2) genes, relative to vehicle control (arbitrarily set at 1), in BEAS-2B cells treated with 6.25 μM (white bars) or 25 μM (black bars) 5-AZA. (b) Fold changes in mRNA expression for the KLK1, KLKB1, BDKRB1, BDKRB2, and high molecular weight kininogen (KNG1) genes, relative to vehicle control (arbitrarily set at 1), in H2126 cells treated with 6.25 μM (white bars) or 25 μM (black bars) 5-AZA. (c) Fold changes in mRNA expression for the KLK1, KLKB1, BDKRB1, BDKRB2, and KNG1 genes, relative to vehicle control (arbitrarily set at 1), in H520 cells treated with 6.25 μM (white bars) or 25 μM (black bars) 5-AZA.
167046.fig.002a
(a)
167046.fig.002b
(b)
167046.fig.002c
(c)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.